ReviewHypertension research : official journal of the Japanese Society of Hypertension2026
The quest for accurate wearable blood pressure monitors.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Real-World Validation for Less-Disturbing Ambulatory Blood Pressure Monitoring (ABPM) in Malaysia Using Huawei Wearables
Who cites it
1 citing paper in PubMed.
- Consumer Smartwatch Technology in Health and Performance Research: Validity, Limitations, and Real-World Applications.Sensors (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The automated cuff-oscillometric blood pressure (BP) measurement currently is the standard method for evaluating hypertension using office, home and ambulatory measurements. It eliminated observer-related issues of the auscultatory method and made out-of-office BP monitoring feasible. But there are issues with this method, mainly due to the limited BP information they provide, the use of an inflatable cuff, and because measurements are provided only in static conditions. Cuffless wearable devices can provide complete information of the individual's BP profile and behavior, for days, weeks, months, unobtrusively, during all routine daily activities and during sleep. However, at the present time there is no convincing evidence that any cuffless BP technology has adequate accuracy as required for clinical use, and scientific societies do not recommend them. Novel tools implemented in smartwatches, such as the Apple 'Hypertension Notification Feature', can be useful in detecting undiagnosed hypertension in the general population, but require confirmation by cuff BP measurement and are not intended for monitoring treated hypertensives. Novel smartwatch-type cuff-oscillometric (not cuffless) BP monitors can be used for self-measurement at home, at work and other settings, and also for ambulatory monitoring including nighttime sleep. Some successful validation studies, mainly on static validation, have been reported, but more research is needed in ambulatory conditions involving motion and position and in clinical use. While continuing to pursue cuffless wearable BP technologies, smartwatch-type cuff-oscillometric devices deserve our close attention for establishing their optimal use.
Indexed as
Identifiers
41193706What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.